Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Dabigatran (Pradaxa) and apixaban (Eliquis) are both anticoagulant medications used to prevent and treat blood clots, and they help lower the risk of stroke in people with atrial fibrillation (AFib) that isn't caused by heart valve problems. However, they have a few differences. Dabigatran is a direct thrombin inhibitor, while apixaban is a direct-acting oral anticoagulant (DOAC) that blocks factor Xa. Dabigatran is available as a lower-cost generic, whereas apixaban is only available as a brand-name medication. Dabigatran is typically dosed at 150 mg twice daily for adults, while apixaban is usually taken at 5 mg twice daily. Dabigatran can cause stomach upset and bleeding, and it has an antidote called Praxbind (idarucizumab) for serious bleeding. Apixaban also increases bleeding risk but has a different antidote called Andexxa (andexanet alfa). Nether medication is recommended for people with mechanical heart valves. Both medications can interact with other medications, including blood-thinning medications, so it's important to discuss all medications you are taking with your healthcare professional.
Dabigatran (Pradaxa)
Eliquis (apixaban)
Dabigatran (Pradaxa)
Eliquis (apixaban)
Summary of Dabigatran vs. Eliquis
Summary for Anticoagulant
Prescription only
Dabigatran etexilate mesylate, also known by its brand name, Pradaxa, is a type of anticoagulant blood thinner that treats and prevents certain types of blood clots in people ages 8 years and older. It's also used to lower the risk of stroke and blood clots in people with atrial fibrillation (AFib). The dosing can differ based on why you need the medication, but it's typically taken by mouth twice a day. Side effects include stomach upset and bleeding. For people who experience serious bleeding with this medication, there's an antidote medication called Praxbind (idarucizumab) that reverses its effects.
Summary for Direct-acting oral anticoagulant (DOAC)